Bill Popomaronis, R.Ph., NCPA vice president, home health and long term care pharmacy services, provides his thoughts and explanations on the latest DME information from CMS.
Wednesday, June 25, 2008
DuoNeb Local Coverage Determination Delayed
The nebulizers local coverage determination, effective for dates of service on or after July 1, 2008, is being revised. The implementation of least costly alternative to the FDA-approved unit dose combination of albuterol sulfate and ipratropium bromide (DuoNeb - J7620) is delayed and will become effective for claims with dates of service on or after November 1, 2008. Suppliers should become familiar with the new Nebulizers Policy prior to its effective date to minimize effects on their billing process.
